CG Oncology, Inc. has been added to Nasdaq Composite Index.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
30.06 USD | +0.27% | +16.76% | 0.00% |
May. 14 | Goldman Sachs Upgrades CG Oncology to Buy From Neutral With $50 Price Target | MT |
May. 09 | CG Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 2B | |
+39.54% | 50.93B | |
-0.29% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+13.16% | 26.02B | |
-22.33% | 18.9B | |
+8.20% | 13.21B | |
+24.14% | 12.17B | |
+30.15% | 12.16B |
- Stock Market
- Equities
- CGON Stock
- News CG Oncology, Inc.
- CG Oncology, Inc.(NasdaqGS: CGON) added to NASDAQ Composite Index